Swiss Pharma, a third-generation family-owned company, brings over 25 years of expertise in the development and manufacturing of high-quality generic and specialty pharmaceuticals. Specializing in sterile dosage forms, we cater to global healthcare markets with a strong presence in more than 80 countries under our own brand name.

Our state-of-the-art cGMP-compliant manufacturing facilities hold accreditations from global regulatory authorities including EU-GMP, Anvisa (Brazil), Cofepris (Mexico), TGA (Australia), and PIC/s, ensuring world-class quality and compliance. With a portfolio of over 1,000 approved dossiers across approximately 190 molecules, we offer both standard and complex dosage solutions to meet varied healthcare needs.

Swiss Pharma also offers customized support to our global distribution partners, providing end-to-end analytical, regulatory, and technical assistance. Our commitment to quality, innovation, and regulatory excellence continues to position us as a preferred partner in the international pharmaceutical landscape.